[pThr3]-CDK5 Substrate (TFA)

[pThr3]-CDK5 Substrate (TFA)

• UNSPSC Description: [pThr3]-CDK5 Substrate TFA is an effective Phospho-Thr3CDK5 Substrate. [pThr3]-CDK5 Substrate is derived from the sequence of the histone H1 peptide that docks in the active site of CDK5. [pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 µM[1].
• Target Antigen: CDK
• Type: Peptides
• Related Pathways: Cell Cycle/DNA Damage
• Applications: Neuroscience-Neuromodulation
• Field of Research: Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/pthr3-cdk5-substrate-tfa.html
• Solubility: H2O
• Smiles: O=C([C@@H]1CCCN1)N[C@@H](CCCCN)C(N[C@]([C@@H](C)OP(O)(O)=O)([H])C(N2[C@@H](CCC2)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O
• Molecular Weight: 1332.45
• References & Citations: [1]Beaudette KN, et al. Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain. J Biol Chem. 1993 Oct 5;268(28):20825-30.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported